Researcher
João Guedelha Sabino
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From10 Jan 2011 → Today
Projects
1 - 8 of 8
- Infrastructure for Targeted ProteomicsFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Making healthier and safer foods: development of a preclinical platform for testing of food componentsFrom22 Sep 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Histological healing in inflammatory bowel diseaseFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Diet to improve disease control in patients with active Crohn diseaseFrom17 Dec 2020 → 30 Sep 2022Funding: BOF - projects
- Combatting chronic diseases and inflammation by eating food that's right for youFrom1 Oct 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Diet to improve disease control in patients with inflammatory bowel diseaseFrom1 Oct 2020 → TodayFunding: FWO fundamental clinical research fellowship
- Molecular classification of IBD: diagnostic and therapeutic potentialFrom1 Jun 2018 → 1 Jun 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Host and environmental factors influencing the intestinal microbiota in ulcerative colitis and primary sclerosing cholangitisFrom1 Oct 2013 → 15 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 124
- Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights. Authors' reply.(2024)
Authors: Matthias Lenfant, Bram Verstockt, João Guedelha Sabino, Séverine Vermeire, Marc Ferrante
Pages: 1007 - 1008 - Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply(2024)
Authors: Matthias Lenfant, Bram Verstockt, João Guedelha Sabino, Séverine Vermeire, Marc Ferrante
Pages: 723 - 724 - Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease.(2024)
Authors: Bram Verstockt, Marc Ferrante, João Guedelha Sabino, Jeroen Raes, Séverine Vermeire
Pages: 483 - 495 - Faecal microbiota transplantation in children: A systematic review(2024)
Authors: João Guedelha Sabino, Karen van Hoeve
- Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study(2024)
Authors: Dahham Alsoud, João Guedelha Sabino, Peter Bossuyt, Séverine Vermeire, Marc Ferrante
- Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study(2024)
Authors: Jo Swinnen, João Guedelha Sabino, Séverine Vermeire, Marc Ferrante
- STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report.(2024)
Authors: Marijke Peetermans, Kathleen Claes, João Guedelha Sabino
Pages: 37 - 39 - The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis(2024)
Authors: Matthias Lenfant, Bram Verstockt, João Guedelha Sabino, Séverine Vermeire, Marc Ferrante
Pages: 1 - 7 - Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease(2023)
Authors: João Guedelha Sabino
Pages: 1723 - 1732 - Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation Study(2023)
Authors: Zhigang Wang, Bram Verstockt, João Guedelha Sabino, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
Pages: 3188 - 3190
Patents
1 - 2 of 2